Evidence map›Paper›PMID 34946319›Full record

ArticleMedicina (Kaunas, Lithuania)2021

Serum Fibroblast Growth Factor 21 Levels in Children and Adolescents with Hashimoto's Thyroiditis before and after l-Thyroxin Medication: A Prospective Study.

Pavlos Drongitis, Eleni P Kotanidou, Anastasios Serbis, Vasiliki Rengina Tsinopoulou, Spyridon Gerou, Assimina Galli-Tsinopoulou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pavlos Drongitis2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece.ORCID 0000-0002-3024-3041
Eleni P Kotanidou2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece.ORCID 0000-0002-8292-4471
Anastasios Serbis2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece.ORCID 0000-0001-5422-3988
Vasiliki Rengina Tsinopoulou2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece.ORCID 0000-0002-2531-2313
Spyridon GerouAnalysi Iatriki S.A., Biopathological Diagnostic Research Laboratories, 54623 Thessaloniki, Greece.
Assimina Galli-Tsinopoulou2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece.ORCID 0000-0002-8503-3893
Aristotle University of Thessaloniki · GR

Funding

Research Committee of the Aristotle University of Thessaloniki 89650
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hashimoto DiseaseThyroxineAdolescentChildChild, PreschoolFibroblast Growth FactorsHumansProspective StudiesThyroid Hormonesfibroblast growth factor 21Fibroblast Growth FactorsThyroid HormonesThyroxineadolescentschildrenfibroblast growth factor 21Hashimoto’s thyroiditisl-thyroxinresting metabolic rate

Identifiers

PMID34946319
PMCPMC8709108
OpenAlexW4200092271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.